Keyphrases
Neurofibromatosis Type 1 (NF-1)
100%
Neurofibromatosis Type I
66%
Tumor
43%
Autism Spectrum Disorder
28%
Autism
23%
Optic Pathway Glioma
21%
Cochlear Implantation
21%
Glioblastoma
20%
Cochlear Implant
20%
Subarachnoid Hemorrhage
19%
Glioma
19%
Astrocytes
18%
Malignant Peripheral Nerve Sheath Tumor (MPNST)
17%
Pediatric
16%
Neurofibromatosis Type 2
16%
Neurofibromin
16%
Magnetic Resonance Imaging
16%
Clinical Trials
15%
Brain Tumor
15%
Hydrocephalus
15%
Confidence Interval
15%
Meningioma
15%
Mouse Model
12%
United States
11%
Cerebrospinal Fluid
11%
Merlin
11%
Overall Survival
10%
Gene Products
10%
Microglia
10%
Pilocytic Astrocytoma
10%
Clinical Outcomes
10%
COVID-19
9%
Speech Perception
9%
Neurofibromatosis
9%
Pediatric Patients
9%
Low-grade Glioma
9%
Aneurysmal Subarachnoid Hemorrhage (aSAH)
9%
Electrocochleography
9%
Central Nervous System
8%
Posthemorrhagic Hydrocephalus
8%
Electronic Health Records
8%
Chemotherapy
8%
Tumor Suppressor
8%
Tuberous Sclerosis Complex
8%
High Risk
8%
Circulating Tumor DNA (ctDNA)
8%
Resection
7%
Odds Ratio
7%
Delayed Cerebral Ischemia
7%
Social Responsiveness Scale
7%
Tumor Growth
7%
Neurodevelopmental Disorders
7%
Clinical Research
7%
Cardiovascular Health
7%
Seizure
7%
Astrocytoma
7%
Progression-free Survival
7%
Dural Arteriovenous Fistula (dAVF)
7%
Plexiform Neurofibroma
7%
Cochlear Implant Users
6%
Gene Expression
6%
Tumor Suppressor Gene
6%
Tumor Cells
6%
Radiation Therapy
6%
Clinical Papers
6%
Photothermal Therapy
6%
Hearing Preservation
6%
Brain Injury
6%
Childhood Autism
6%
Hazard Ratio
6%
Risk Factors
6%
Older Adults
6%
Clinical Features
6%
Research Consortium
6%
Hydrocephalus Clinical Research Network
6%
Quality of Life
6%
White Matter
6%
Syringomyelia
6%
Central Nervous System Tumors
6%
Autistic Traits
5%
Silent Cerebral Infarction
5%
Alzheimer's Disease
5%
Coronavirus Disease (COVID)
5%
Cell Growth
5%
Sickle Cell Anemia
5%
Biomedical Informatics
5%
Sickle Cell Disease
5%
Pediatric Low-grade Glioma
5%
Translational Research
5%
Breast Cancer
5%
Chiari Malformation Type I
5%
Sarcoma
5%
Nervous System
5%
Natural History
5%
Glioma Growth
5%
Pediatric Brain Tumor
5%
Comorbidity
5%
Brain Development
5%
Phase II Study
5%
Endoscopic Third Ventriculostomy
5%
Medicine and Dentistry
Neurofibromatosis Type I
68%
Neoplasm
67%
Ganglioglioma
41%
Pediatrics
36%
Diseases
25%
Surgery
23%
Cochlear Implant
20%
Magnetic Resonance Imaging
20%
Cochlear Implantation
19%
Malignant Neoplasm
17%
Apoplexy
17%
Intracranial Tumor
16%
Clinical Trial
15%
Glioblastoma
14%
Subarachnoid Hemorrhage
13%
Malignant Peripheral Nerve Sheath Tumor
12%
COVID-19
12%
Hydrocephalus
12%
Radiation Therapy
12%
Recurrent Disease
11%
Arnold Chiari Malformation
11%
Breast Cancer
10%
Plexiform Neurofibroma
10%
Overall Survival
9%
Neurofibromatosis
9%
Cancer
9%
Tumor Progression
9%
Meningioma
9%
Speech Perception
9%
Electrocochleography
9%
Sickle-Cell Disease
9%
Diagnosis
8%
Optic Nerve Glioma
8%
Neurofibromatosis Type II
8%
Brain Ischemia
8%
Electronic Health Record
8%
Clinical Research
8%
Epileptic Seizure
7%
Dural Arteriovenous Fistula
7%
Cardiovascular System
7%
Carcinogenesis
7%
Central Nervous System
7%
Pediatrics Patient
7%
Microglia
7%
Odds Ratio
7%
Cerebrospinal Fluid
7%
Circulating Tumor DNA
7%
Aneurysm
7%
Biological Marker
6%
Pilocytic Astrocytoma
6%
Infection
6%
Cerebral Hemorrhage
6%
Traumatic Brain Injury
6%
Clinician
6%
Connective Tissue Cancer
6%
Metastatic Carcinoma
6%
Syringomyelia
6%
Hearing Impairment
5%
Surgeon
5%
Progression Free Survival
5%
Quality of Life
5%
Computer Assisted Tomography
5%
Bleeding
5%
Cochlea
5%
Brain Infarction
5%
Biopsy Technique
5%
Immunotherapy
5%
Melanoma
5%
In Vitro
5%
Round Window
5%
Cardiovascular Disease
5%
Cell Signaling Pathway
5%